欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/2636/003
药品名称TRIPLIXAM 5 mg / 1,25 mg / 10 mg, filmomhulde tabletten
活性成分
    • amlodipine 10.0 mg
    • indapamide 1.25 mg
    • perindopril arginine salt 5.0 mg
剂型Film-coated tablet
上市许可持有人Les Laboratoires Servier 50 rue Carnot 92284 Suresnes Cedex France
参考成员国 - 产品名称Netherlands (NL)
Triplixam 5 mg/ 1,25mg/10 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Ireland (IE)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Croatia (HR)
    • Belgium (BE)
许可日期2013/12/17
最近更新日期2024/03/28
药物ATC编码
    • C09BX01 perindopril, amlodipine and indapamide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase